Halfway through the Clinical Study Optimizing Cellsway’s CTC Workflow for Enhanced Cancer Care
The 300-patient study is designed for optimizing Cellsway’s CTC enrichment, identification and characterization workflow with clinical samples. The patients for the study are being selected from newly diagnosed Stage III/IV …